Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation

Author： Yoshino Munehiro  

Publisher： Springer Publishing Company

ISSN： 1341-321X

Source： Journal of Infection and Chemotherapy, Vol.18, Iss.2, 2012-04, pp. : 169-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E43-E52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 85-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination Therapy Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Associated with Hepatic Failure

By  

Current Drug Safety, Vol. 7, Iss. 5, 2012-11 ,pp. : 391-393

Bentham Science Publishers

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug‐resistant strains of hepatitis B virus

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2265-2274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug‐resistant strains of hepatitis B virus

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 10, 2015-10 ,pp. : 2265-2274

John Wiley & Sons Inc

Access to resources Recommend Favorite